Raybow Tablet 100 mg (Lasmiditan Hemisucsinate)

Adult dose

This medicine should not be taken to prevent migraine. ○ Adults The recommended dose is 50mg, 100mg, or 200mg orally as a single dose, as needed. Do not take more than one dose within 24 hours, and do not drive or operate machinery within 8 hours after taking this medicine. A second dose of this medicine for the same migraine attack has been shown to be ineffective. The safety of treatment for more than an average of 4 migraine attacks per 30 days has not been established. This medicine may be taken with or without food. Patients with renal impairment No dose adjustment is needed based on renal function. Patients with hepatic impairment No dose adjustment is needed in patients with mild or moderate hepatic impairment (Child-Pugh A or B). This medicine has not been studied in patients with severe hepatic impairment (Child-Pugh C), and use in these patients is not recommended.

This medication should not be administered to certain patients. It should not be used if there is an allergy to this medication or any of its components. Patients with severe liver dysfunction should also avoid using this medication. Patients who need to take caution when using this medication include those with uncontrolled hypertension, those taking alcohol or other central nervous system depressants, women who are pregnant or may become pregnant, and women who are breastfeeding. Additionally, elderly patients should also take caution when using this medication. Common side effects when taking this medication include dizziness, fatigue, sensory abnormalities, drowsiness, and other various side effects have been reported, including nausea, muscle weakness, anxiety, tremors, and sleep disorders. Rarely, serious allergic reactions may occur, so any unusual symptoms should be immediately discussed with a healthcare professional. This medication can lower heart rate and temporarily raise blood pressure, so patients with heart disease or those taking medications that lower heart rate should consult with their physician. This medication is intended for use in migraine patients only, and activities requiring concentration, such as driving or operating machinery, should be avoided for at least 8 hours after taking it. This is because the medication can cause drowsiness or impair concentration, affecting safety. Taking this medication with alcohol or other central nervous system depressants may increase sedative effects, so caution is needed when combined. When used with other medications that increase serotonin levels, there is a risk of serious side effects known as serotonin syndrome, so it must be discussed with a physician. Additionally, this medication has a potential for abuse, so signs of drug abuse should be carefully monitored during use. Women who are pregnant or breastfeeding should consult with a physician before use, as the safety of this medication has not been sufficiently established. It is not used in pediatric patients, as safety and efficacy have not been confirmed. Elderly patients may experience dizziness or increased blood pressure more frequently due to this medication, so dosage should be adjusted and used cautiously.

• Dizziness
• fatigue
• sensory abnormalities
• sedation
• nausea and vomiting
• muscle weakness
• lightheadedness
• coordination disorders
• somnolence
• visual disturbances

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. The safest storage temperature is between 1 degree and 30 degrees Celsius.

Appearance

Bright purple oval film-coated tablet

Package unit

2 tablets/box [2 tablets/PTP X 1], 6 tablets/box [2 tablets/PTP X 3], 12 tablets/box [2 tablets/PTP X 6], 16 tablets/box [2 tablets/PTP X 8]